Wall Street May Be Sleeping on This Massive AI CPU Opportunity

Arm Holdings (NASDAQ:ARM | ARM Price Prediction) has quietly become the CPU backbone of the AI data center buildout, and the market isn’t fully pricing it in. Between hyperscaler design wins, a rapidly ramping first-party silicon business, and a data center royalty line that more than doubled year over year again, the setup is stronger than the price action suggests.

Our 24/7 Wall St. price target for Arm is $265.32, implying 10.99% upside from $239.05. The recommendation is buy, with confidence at 90%.

24/7 Wall St. Price Target Summary

A Wild Ride Into the AGI CPU Launch

Arm has been one of the most volatile mega-caps of 2026. Shares are up 118.69% year to date and 67.7% over the past year, but down 1.75% over the past week after a 6.33% drop on August 28. Shares sit roughly halfway between the 52-week low of $100.02 and high of $452.70.

Q1 FY2027 revenue landed at $1.289 billion, up 22.41% YoY and beat consensus, though GAAP EPS of $0.25 missed the $0.4038 estimate as opex climbed 28% to $1.16 billion. Non-GAAP EPS came in at 45 cents, up 29%, above guidance, with data center royalty revenue more than doubling.

Why Bulls See a Breakout to $422

The bull case is straightforward: the Arm AGI CPU is now a real revenue line. Management said demand exceeds $2 billion versus the $1 billion opportunity outlined last quarter across fiscal 2027 and 2028, with Meta, OpenAI, Cerebras, Cloudflare, and Oracle named as customers.

CEO Rene Haas told investors, “Our confidence in achieving upside to our $1 billion opportunity for the ArmAGI CPU business has increased in the past 90 days.”

Arm holds roughly 50% CPU compute share among top hyperscalers, and management flagged peer TAM estimates as high as $200 billion, suggesting its own $100 billion by 2030 data center CPU forecast may be conservative. Our bull case takes shares to $422.36, a 76.68% gain, matching the Street high near the $452.70 52-week high.

What Could Go Wrong

Valuation is the key risk. Arm trades at a trailing P/E of 246 and forward P/E of 115, versus a beta of 3.9. Q1 operating margin compressed to 7% from 11%, though net income was flattered by $128 million in unrealized equity gains.

Bulls note opex pressure reflects heavy R&D ($838 million) tied to the AGI CPU ramp, and non-GAAP operating margin actually expanded 200 basis points year over year to about 41%. The Qualcomm litigation goes to trial in Q4 2026, and China exposure ($200 million in Q1) sits inside tightening export controls. Our bear case targets $212.73.

How Arm Compares to NVIDIA and Qualcomm

NVIDIA (NASDAQ:NVDA) selected Arm’s architecture for its Vera CPU in next-gen AI systems. NVIDIA trades at a forward P/E of 26 against 105.9% YoY revenue growth, dramatically cheaper than Arm’s 115x forward multiple. That gap underpins the bear valuation argument, though Arm’s IP-royalty model deserves a premium.

Qualcomm (NASDAQ:QCOM) is both litigation counterparty and emerging data center CPU rival via its Arm-based Dragonwing C1000. Qualcomm trades at a forward P/E of 16 with revenue declining 4% YoY, showing what a mature semi multiple looks like. The gap validates Arm’s premium as long as royalty growth stays above 20%. Our $265.32 target sits well below the analyst consensus of $286.44.

Verdict: Buy Rating With Weakness as an Entry Setup

My verdict is a buy with 90% confidence and a 24/7 Wall St. price target of $265.32. AGI CPU demand has doubled to over $2 billion in 90 days, and Arm has secured the wafer, substrate, and test capacity to fulfill it.

Investors with tolerance for the elevated beta may find the risk/reward more attractive on any pullback toward the 200-day moving average near $198.91. Caution is warranted if the Qualcomm trial produces adverse rulings or if smartphone royalty growth slips below the high teens.

Here is where our model projects Arm could trade, assuming current AGI CPU adoption trends and 20%-plus royalty growth hold.

These projections assume Arm executes on the AGI CPU roadmap and defends hyperscaler share. Significant upside or downside could result from the Qualcomm trial outcome or a step-change in AI infrastructure spending.

Contact [email protected] for any questions or corrections.